Erratum: Geraniol and β-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity (Biochemical Pharmacology (2004) 68 (1739-1747) DOI: 10.1016/j.bcp.2004.06.022);Geraniol and β-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity

Biochemical Pharmacology

Volumn 68, Issue 9, 2004, Pages 1739-1747

  Duncan, Robin E ^a   Lau, Dominic ^a   El Sohemy, Ahmed ^a   Archer, Michael C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

3 Hydroxy 3 methylglutaryl coenzyme A reductase; Cell cycle; Cyclin dependent kinase 2; MCF 7 human breast cancer cells; Mevalonate; Plant isoprenoids

Indexed keywords

ANTINEOPLASTIC AGENT; BETA IONONE; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; GERANIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ISOPRENOID; MEVALONIC ACID; PROTEIN P21; PROTEIN P27;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; METAPHASE; MITOSIS INHIBITION; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 4644256898     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.11.001     Document Type: Erratum

References (48)

1. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 1990 425 430
2. M.H. Gelb Protein prenylation, et cetera: signal transduction in two dimensions Science 275 1997 1750 1751
3. V.R. Quesney-Huneeus, M.H. Wiley, and M.D. Siperstein Essential role for mevalonate synthesis in DNA replication Proc. Natl. Acad. Sci. U.S.A. 76 1979 5056 5060
4. J. Wejde, H. Blegen, and O. Larsson Requirement for mevalonate in the control of proliferation of human breast cancer cells Anticancer Res. 12 1992 317 324
5. S. Yachnin Mevalonic acid as an initiator of cell growth Studies using human lymphocytes and inhibitors of endogenous mevalonate biosynthesis Oncodev. Biol. Med. 3 1982 111 123
6. F. Bennis, G. Favre, F. Le Gaillard, and G. Soula Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549 Int. J. Cancer 55 1993 640 645
7. A. El-Sohemy, and M.C. Archer Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations Carcinogenesis 21 2000 827 831
8. H.J. Harwood Jr., I.M. Alvarez, W.D. Noyes, and P.W. Stacpoole In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma J. Lipid Res. 32 1991 1237 1252
9. S. Kawata, K. Takaishi, T. Nagase, N. Ito, Y. Matsuda, and S. Tamura Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis Cancer Res. 50 1990 3270 3273
10. K.N. Rao, M.F. Melhem, H.F. Gabriel, E.D. Eskander, M.E. Kazanecki, and J.S. Amenta Lipid composition and de novo cholesterogenesis in normal and neoplastic rat mammary tissues J. Natl. Cancer Inst. 80 1988 1248 1253
11. M. Jakobisiak, and J. Golab Potential antitumor effects of statins Int. J. Oncol. 23 2003 1055 1069
12. P.L. Crowell Prevention and therapy of cancer by dietary monoterpenes J. Nutr. 129 1999 775S 778S
13. C.E. Elson, and S.G. Yu The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables J. Nutr. 124 1994 607 614
14. C. Elson Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease J. Nutr. 125 1995 1666S 1672S
15. C.E. Elson, D.M. Peffley, P. Hentosh, and H. Mo Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer Proc. Soc. Exp. Biol. Med. 221 1999 294 311
16. J.A. McAnally, M. Jung, and H. Mo Farnesyl-o-acetylhydroquinone and geranyl-o-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells Cancer Lett. 202 2003 181 912
17. P.L. Crowell, W.S. Kennan, J.D. Haag, S. Ahmad, E. Vedejs, and M.N. Gould Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene Carcinogenesis 13 1992 1261 1264
18. W.A. Russin, J.D. Hoesly, C.E. Elson, M.A. Tanner, and M.N. Gould Inhibition of rat mammary carcinogenesis by monoterpenoids Carcinogenesis 10 1989 2161 2164
19. C.E. Elson, T.H. Maltzman, J.L. Boston, M.A. Tanner, and M.N. Gould Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis Carcinogenesis 9 1988 331 332
20. S. Bardon, V. Foussard, S. Fournel, and A. Loubat Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression Cancer Lett. 181 2002 187 194
21. S. Bardon, Picard, and P. Martel Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines Nutr. Cancer. 32 1998 1 7
22. J.A. Elegbede, C.E. Elson, A. Qureshi, M.A. Tanner, and M.N. Gould Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene Carcinogenesis 5 1984 661 664
23. H. Mo, and C.E. Elson Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids J. Nutr. 129 1999 804 813
24. S.M. Shoff, M. Grummer, M.B. Yatvin, and C.E. Elson Concentration- dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol Cancer Res. 51 1991 37 42
25. R.A. Parker, B.C. Pearce, R.W. Clark, D.A. Gordon, and J.J. Wright Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase J. Biol. Chem. 268 1993 11230 11238
26. W. Shi, and M.N. Gould Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol Carcinogenesis 23 2002 131 142
27. P.M. Ghosh, M.L. Moyer, G.E. Mott, and J.I. Kreisberg Effect of cyclin E overexpression on lovastatin-induced G1 arrest and RhoA inactivation in NIH 3T3 cells J. Cell. Biochem. 74 1999 532 543
28. U. Laufs, D. Marra, K. Node, and J.K. Liao 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing Rho GTPase-induced down-regulation of p27(kip1) J. Biol. Chem. 274 1999 21926 21931
29. H. Oda, B.L. Kasiske, M.P. O'Donnell, and W.F. Keane Effects of lovastatin on expression of cell cycle regulatory proteins in vascular smooth muscle cells Kidney Int. 56 1999 202 205
30. W.H. Park, Y.Y. Lee, E.S. Kim, J.G. Seol, C.W. Jung, and C.C. Lee Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis Anticancer Res. 19 1999 3133 3140
31. S. Rao, M. Lowe, T.W. Herliczek, and K. Keyomarsi Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53 Oncogene 17 1998 2393 2402
32. C. Ukomadu, and A. Dutta Inhibition of CDK2 activating phosphorylation by mevastatin J. Biol. Chem. 278 2003 4840 4846
33. X. Hu, K.M. White, N.E. Jacobsen, D.J. Mangelsdorf, and L.M. Canfield Inhibition of growth and cholesterol synthesis in breast cancer cells by oxidation products of beta-carotene J. Nutr. Biochem. 9 1998 567 574
34. N. Ferri, L. Arnaboldi, A. Orlandi, K. Yokoyama, R. Gree, and A. Granata Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation Biochem. Pharmacol. 62 2001 1637 1645
35. R.J. Ruch, and K. Sigler Growth inhibition of rat liver epithelial tumor cells by monoterpenes does not involve ras plasma membrane association Carcinogenesis 15 1994 787 789
36. R.J. Gillies, N. Didier, and M. Denton Determination of cell number in monolayer cultures Anal. Biochem. 159 1986 109 113
37. A. El-Sohemy, and M.C. Archer Regulation of mevalonate synthesis in LDL receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids Lipids 34 1999 1037 1043
38. G.H. Ripple, M.N. Gould, J.A. Stewart, K.D. Tutsch, R.Z. Arzoomanian, and D. Alberti Phase I clinical trial of perillyl alcohol administered daily Clin. Cancer Res. 4 1998 1159 1164
39. G.H. Ripple, M.N. Gould, R.Z. Arzoomanian, D. Alberti, C. Feierabend, and K. Simon Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day Clin. Cancer Res. 6 2000 390 396
40. D.O. Morgan Principles of CDK regulation Nature 374 1995 131 134
41. M.D. Siperstein, and V.M. Fagan Deletion of cholesterol-negative feedback system in liver tumors Cancer Res. 24 1964 1108 1115
42. D.M. Peffley, and A.K. Gayen Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at the post-transcriptional level J. Nutr. 133 2003 38 44
43. waf1/cip1/sdi1 in a p53-independent manner J. Biol. Chem. 272 1997 27224 27229
44. M.H. Gelb, F. Tamanoi, K. Yokoyama, F. Ghomashchi, K. Esson, and M.N. Gould The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol Cancer Lett. 91 1995 169 175
45. Z. Ren, C.E. Elson, and M.N. Gould Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH 3T3 cells Biochem. Pharmacol. 54 1997 113 120
46. Z. Ren, and M.N. Gould Modulation of small G protein isoprenylation by anticancer monoterpenes in in situ mammary gland epithelial cells Carcinogenesis 19 1998 827 832
47. R.J. Hohl, and K. Lewis Differential effects of monoterpenes and lovastatin on ras processing J. Biol. Chem. 270 1995 17508 175012
48. R.L. Jirtle, J.D. Haag, E.A. Ariazi, and M.N. Gould Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors Cancer Res. 53 1993 3849 3852